Canton Hathaway’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Canton Hathaway's LLY Position: Q2 2026 in Review
Canton Hathaway reduced its Eli Lilly (LLY) stake by 62% in Q2 2026, selling an estimated $1.43M and leaving 873 shares worth $1.05M. The position accounts for 0.2% of the portfolio, ranked #63.
Canton Hathaway first reported a position in LLY in Q2 2019 and has held it in 29 quarters since. The position peaked at $2.3M in Q4 2025. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Canton Hathaway held 873 shares of Eli Lilly worth $1.05M as of Q2 2026.
- Canton Hathaway sold 1,400 Eli Lilly shares in Q2 2026, an estimated $1.43M.
- Eli Lilly made up 0.2% of Canton Hathaway's portfolio in Q2 2026, its #63 holding.
- Canton Hathaway first reported a position in Eli Lilly in Q2 2019 and has held it in 29 quarters since.
- Canton Hathaway's Eli Lilly position peaked at $2.3M in Q4 2025.
- 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Canton Hathaway's 13F filing for Q2 2026, filed 6 Aug 2026.